[1]田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510-封3.
　TIAN Yongchao..Progress in prevention and treatment of intestinal mucosal barrier dysfunction in sepsis[J].,2020,49(4):510-封3.
点击复制

脓毒症肠黏膜屏障功能障碍防治研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年4期
页码:
510-封3
栏目:
综述
出版日期:
2020-04-05

文章信息/Info

Title:
Progress in prevention and treatment of intestinal mucosal barrier dysfunction in sepsis
文章编号:
DOI:10.3969/j.issn.10007377.2020.04.031
作者:
田永超
天津中医药大学第一附属医院(天津300381)
Author(s):
TIAN Yongchao.
The First Affiliated Hospital of Tianjin University ofTraditional Chinese Medicine(Tianjin 300381)
关键词:
脓毒症;  肠黏膜屏障;  防治;  危重征;  预后
Keywords:
Sepsis;  Intestinal mucosal barrier;  Prevention and treatment;  Critically ill;  Prognosis
分类号:
R63
文献标志码:
A
摘要:
脓毒症一直是国内外危重病医学界研究的热点、重点和重大疑难问题。肠道在体内具有独特的生理环境及特殊生理构造,参与了脓毒症等危重病的病理生理过程。肠屏障功能已成为评价危重病预后的关键指标之一,如何在治疗严重脓毒症时尽早改善肠缺血,恢复受损的肠黏膜屏障功能,是目前治疗严重脓毒症的关键之一。本文对近年来肠黏膜屏障功能障碍的防治进行综述。
Abstract:
Abstract Sepsis has always been a hot,important and difficult problem in the field of critical care medicine at home and abroad. Intestinal tract has a unique physiological environment and special physiological structure in vivo,and participates in the pathophysiological process of severe diseases such as sepsis. Intestinal barrier function has become one of the key indicators to evaluate the prognosis of critical illness. How to improve intestinal ischemia and restore the damaged intestinal barrier function as early as possible is one of the key factors to treat severe sepsis at present. This article reviews the prevention and treatment of intestinal mucosal barrier dysfunction in recent years.

参考文献/References:

[1] Prescott HC,Angus DC. Enhancingrecovery from sepsis:A review[J].JAMA,2018,319(1):62-75.
[2] Baumgart DC,Dignass AU.Intestinal barrier function[J].Curr Opin Clin Nutr Metab Care,2002,5(6):685-694.
[3] 刘 刚,王 强,王育红.肠屏障功能与多器官功能障碍综合征[J].海军总医院学报,2008,21(2):32-38.
[4] 赵亚娟,富建华,孙 梅.谷氨酰胺影响脓毒症大鼠脑内PDGF及其受体表达的研究[J].中国当代儿科杂志,2010,12(12):967-971.
[5] 郭焱芳,张 彬. 谷氨酰胺对肠道免疫调节作用的研究进展[J]. 中国兽医杂志,2010,46(8):62-64.
[6] Lu JF, Tong H, Chen R,et al.Prediction of the prognosis of peripheral blood CD14+ mononuclear cells HLA-DR on the prognosis of senile traumatic sepsis [J]. Liberation Army Med J,2016,41(7):570-574.
[7] Jing L,Wu Q,Wang F. Glutamine induces heat-shock protein and protects against Escherichia colilipopolysaccharide-induced vascular hyporeactivity in rats[J].Crit Care,2007,11(2):34.
[8] Ko HM,Oh SH,Bang HS,et al.Glutamine protectsmice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1[J]. J Immunol,2009,182(12):7957-7962.
[9] 王 辉,范婵娟,张佳莹,等.谷氨酰胺对内毒素血症大鼠肠黏膜屏障的作用[J].中国卫生检验杂志,2013,23(2):355-356.
[10] 沈丽娟,王 倩,吴锡平,等.谷氨酰胺对脓毒症大鼠急性肠黏膜损伤的保护作用[J].内科急危重症杂志,2018,24(3):253-255,260.
[11] 孙莹杰,曹惠鹃,张铁铮,等.N-乙酰半胱氨酸对体外循环期间大鼠肠屏障功能的影响[J].天津医药,2009,37(2):128-130.
[12] Jin X,Wang L,WU HS,et al.N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemic-reperfusion injury in mice[J].Hepatobiliary Pancreat Dis Int 2007,6(3):284-289.
[13] 周晓燕,杜东书,马小波,等. N-乙酰-L-半胱氨酸减轻大鼠胃缺血/再灌注损伤的机制[J].生理学报,2010,62(1):69-72.
[14] 张小龙,邬善敏,许 汉,等. N-乙酰半胱氨酸对梗阻性黄疸大鼠肠黏膜屏障的保护作用[J].武汉大学学报:医学版,2010,31(3):320-323.
[15] Ocal K,Avlan D,Cinel I,et al.The effect of N-acetylcysteine on oxidative stress in intestine and bacterial translocation after thermal injury[J].Burns,2004,30(8):778-784.
[16] 刘晓毅,车向明.乌司他丁通过抑制肠黏膜细胞凋亡减轻大鼠肠道缺血-再灌注损伤[J].西安交通大学学报:医学版,2010,31(5):566-569.
[17] 王立峰,王 磊,陈俊杰,等.乌司他丁对脓毒症大鼠肠屏障保护抗凋亡机制研究[J].临床急诊杂志,2017,18(9):686-689.
[18] 黄 巍.乌司他丁对重症脓毒症患者肠屏障功能及菌群移位的影响[J].临床医学研究与实践,2018,3(1):16-17.
[19] 孙 勇,孙曙光,王 静,等. 谷氨酰胺联合乌司他丁对严重烧伤大鼠肠黏膜屏障及炎症因子的影响[J].南京医科大学学报:自然科学版,2010,30(10):1389-1412.
[20] Lutgendorff F,Akkermans LM,Soderholm JD.The role of microbiota and probiotics in stress-induced gastro-intestinal damage[J].Curr Mol Med,2008,8(4):282-298.
[21] Resta-Lenert S,Barrett KE.Live probiotics protect intestinal epithelial cells from the effects of infection with enterroinvasive escherichiacoil(EIEC)[J]. Gut,2003,52(7):988-997.
[22] Llewellyn A,Foey A. Probiotic modulation of innate cell pathogen sensing and signaling events [J].Nutrients,2017,9(10):1156.
[23] Isolauri E,Sutas Y,Kankaanpaa P,et al.Probiotics:effects on immunity[J].Am J Clin Nutr,2001,73:444-450.
[24] Stack HM,Kearney N,StantonC,et al.Association of beta-glucan endogenous production with increased stress tolerance of intestinal lactobacilli[J].Appl Environ Microbiol,2010,76(2):500-507.
[25] 秦环龙,苏振东,范小兵.益生菌对急性胰腺炎大鼠肠道微生态及紧密连接的影响[J].中国临床营养杂志,2006,14(2):82-86.
[26] 李晗宇,陈路芳,李金优,等. 益生菌制剂对脓毒症小鼠生存情况的影响及机制研究 [J/CD]. 中华危重症医学杂志:电子版,2017,10(5):289-295.
[27] 李素彦,徐 鑫,杨运强,等. 不同时期应用益生菌对脓毒症患者肠道菌群及短链脂肪酸的影响[J].河北医药,2015,37(23):3567-3571.
[28] 张克忠,刘永锋,张佳林.牛磺酸对大鼠胰岛活性和功能的保护作用[J].世界华人消化杂志,2008,16(13):1388-1395.
[29] 王伟阳.内毒素血症大鼠肠道内毒素移位的研究[J].生理学进展,1995,26(1):41-44.
[30] Vaquero E,Gukovsky I,Zaminovic V,et al.Localized pa -ncreatic NF-κB activation and inflammatory response in taurocholate-induced pancreatitis[J].Am J Physiol Gastrointest Liver Physiol,2001,280(6):1197-1208.
[31] 连淑君,王琳琳,唐 清,等. 牛磺酸对内毒素血症幼鼠肠屏障功能障碍的保护作用[J].临床儿科杂志,2010,28(10):950-954.
[32] Su MX,李小刚.依达拉奉治疗急性脑出血并发SIRS致MODS的研究进展[J].医学综述,2008,14(16):2509-2511.
[33] Tomatsuri N,Yoshida N,Takagt T,et al.Edaravone,a newly developed radical scavenge,protects against ischemia-reperfusion injury of the small intestine in rats[J].Int J Mol Med,2004,13(1):105-109.
[34] Mori T,Yamamoto H,Tabata T,et al.A free radical scavenger,edaravone(MCI-186),diminishes intestinal neutrophilipid peroxidation and bacterial translocation in a rat hemorrhagic shock model[J].Crit Care Med,2005,33(5):1064-1069.
[35] 宋祖军,王 燃,刘 健,等.依达拉奉对失血性休克后的肠屏障功能障碍的保护作用[J].中国急救医学,2007,27(3):243-245.
[36] 康义华.依达拉奉对大鼠小肠缺血再灌注损伤保护作用的实验研究[D].昆明:昆明医学院,2010.
[37] Kalafatakis K,Triantafyllou K. Contribution of neurotensin in the immune andneuroendocrine modulation of normal and abnormal enteric function[J].Regul Pept,2011,170(1/3):7-17.
[38] DiFruscia P,He Y,Koenig M,et al.The discovery of indole full agonists of the neurotensin receptor 1( NTSR1)[J].Bioorg Med Chem Lett,2014,24(16):3974-3978.
[39] Zhao D,Pothoulakis C.Effects of NT on gastrointestinal motility and secretion,and role in intestinal inflammation[J].Peptides,2006,27(10):2434-2444.
[40] Assimakopoulos SF,Scopa CD,Nikolopoulou VN,et al. Pleiotropic effects of bombesin and neurotensin on intestinal mucosa:not just trefoil peptides[J].World J Gastroenterol,2008,14(22):3602-3603.
[41] 张 嘉,吕德超.肠道屏障功能监测方法的现状及进展[J].中国急救复苏与灾害医学杂志,2007,10:630-633.
[42] Assimakopoulos SF,Scopa CD,Zervoudakis G,et al.Bo -mbesin and neurotensin reduce endotoxemia,intestinal oxidative stress,and apoptosis in experimental obstructive jaundice[J].Ann Surg,2005,241(1):159-167.
[43] 文黎明,张 正,陈先菊,等.神经降压素对失血-感染大鼠肠道细菌易位的实验研究[J].中国微生态学杂志,2002,14(5):258-261.
[44] 吴友平,杨 静,彭 捷,等.帕瑞昔布钠对脓毒症小鼠肠黏膜屏障的保护作用[J].临床麻醉学杂志,2017,33(11):1091-1095.
[45] 李杜鹏,方德舟,王映珍,等.艾司洛尔对脓毒症大鼠肠道保护作用的实验研究[J].中国急救医学,2017,37(1):37-42.
[46] 陈 丽.MFG-E8对肠黏膜保护作用的研究进展[J].胃肠病学和肝病学杂志,2015,24(5):609-611.
[47] Li Q,Wang C,Tang C,et al.Successful treatment of severe sepsis and diarrhea aftervagotomy utilizing fecal microbiota transplantation:a case report[J].Critical Care,2015,19(1):1-12.

相似文献/References:

[1]李文军,于代华,宗 雷,等.脾多肽注射液对脓毒症患者血清炎症因子及免疫功能的影响*[J].陕西医学杂志,2019,(4):463.
　LI Wenjun,YU Daihua,ZONG Lei,et al.Effect of spleen peptide injection on serum inflammatory factors and immune function in patients With Sepsis[J].,2019,(4):463.
[2]商跃云,张 慧,林书祥,等.脓毒症患儿外周血CD4+T细胞Bip、ATF6及DDIT3表达水平变化[J].陕西医学杂志,2019,(6):706.
　SHSNG Yueyun,ZHANG Hui,LIN Shuxiang,et al.Changes of immunoglobulin binding protein, activating transcription factor 6 and DNA-damage-inducible transcript 3 protein levels in CD4+T cells in children with sepsis[J].,2019,(4):706.
[3]王 婷,韦小碗,杨 亮,等.脓毒症患者血清PCT、CRP、IL-6 和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
　WANG Ting,WEI Xiaowan,YANG Liang,et al.Expression of serum PCT,CRP,IL-6 and IL-10 in patients with sepsis and their clinical diagnostic value[J].,2020,49(4):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
[4]肖武强,董 磊,吴先正△.急性胃肠损伤分级联合D-乳酸、内毒素水平测定对脓毒症患者预后的评估价值*[J].陕西医学杂志,2020,49(12):1577.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.010]
[5]刘应莉,王艳荣,张秋瓒.肠道菌群-过氧化物酶体增殖物激活受体信号通路及其在代谢相关脂肪性肝病发病中的作用研究进展[J].陕西医学杂志,2021,50(9):1166.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.031]
　LIU Yingli,WANG Yanrong,ZHANG Qiuzan.Research progress of intestinal flora-PPAR signaling pathway and its role in pathogenesis of MAFLD[J].,2021,50(4):1166.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.031]
[6]张 瑜,王 娟.脓毒症并发急性呼吸窘迫综合征患者血清血管内皮钙黏蛋白、血管生成素2表达及与预后相关性研究[J].陕西医学杂志,2022,51(2):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
　ZHANG Yu,WANG Juan.Expression of serum vascular endothelial cadherin and angiopoietin 2 in sepsis patients complicated with acute respiratory distress syndrome and their correlation with prognosis[J].,2022,51(4):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
[7]王兴程,张向宁,侯崇智,等.右美托咪定在脓毒症治疗中的作用及机制研究进展[J].陕西医学杂志,2022,51(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
　WANG Xingcheng,ZHANG Xiangning,HOU Chongzhi,et al.Research progress on the role and mechanism of dexmedetomidine in the treatment of sepsis[J].,2022,51(4):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
[8]梁 红,霍红艳.右美托咪定对盲肠结扎穿孔术诱导的脓毒症大鼠急性肺损伤保护作用及其与磷酸化JAK激酶2/酪氨酸磷酸化通路的关系[J].陕西医学杂志,2023,52(1):12.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.003]
　LIANG Hong,HUO Hongyan.Protective effect of dexmedetomidine on CLP-induced acute lung injury in rats with sepsis and its relationship with JAK2/STAT3 pathway[J].,2023,52(4):12.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.003]
[9]廖崇皓,徐岸楠,李世瑶,等.血清壳多糖酶3样蛋白1和几丁质酶1在脓毒症新生儿中的表达变化及其临床价值研究[J].陕西医学杂志,2024,(3):368.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.017]
　LIAO Chonghao,XU Annan,LI Shiyao,et al.Expression changes of serum chitosinase 3-like protein 1 and chitinase 1 in neonatal sepsis and their clinical value[J].,2024,(4):368.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.017]
[10]吴泽华,李跃东,戴莹莹,等.降钙素原、C反应蛋白、白细胞计数和中性粒细胞比率在重症医学科脓毒症治疗预后判断中的临床价值[J].陕西医学杂志,2024,(4):540.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.023]

更新日期/Last Update: 2020-04-13